Advances in the field of artificial intelligence (AI) over the past couple of years have come fast and furious. Arguably, one of the biggest beneficiaries of this trend is Nvidia (NVDA 0.40%).
Popular, Inc.'s Series A Preferred Shares offer a yield near 6.5% with monthly dividends that have been paid without interruption for more than 20 years. Puerto Rican banks, including Popular, Inc., benefit from an oligopolistic market. Popular, Inc. has improved several financial metrics since I last covered its Series A Preferred Shares in 2020.
Ozempic and other semaglutide drugs help people reduce their drinking, a new study has found.
I focus on finding great stocks rather than avoiding bad ones - good investments are rare, while weak stocks are easy to spot. This approach adds more value. Bearish articles often lead to defensive reactions rather than insightful discussions. I prefer constructive engagement, making my analysis more valuable to readers. That said, I highlight a few well-known dividend stocks I would avoid. My goal isn't to convince anyone to sell, but to provide food for thought and perspective.
Palantir Technologies (PLTR 23.99%) and Tesla (TSLA 2.22%) were two of the most popular stocks among retail investors last year as measured by net inflows. But most Wall Street analysts expect both stocks to decline this year.
Exchange-traded funds (ETFs) have transformed the investing landscape since their 1993 debut, attracting investors with their straightforward approach to diversification. By allowing individuals to buy shares that track entire market indexes or sectors, ETFs eliminate the challenge and risk of selecting individual stocks while keeping costs minimal.
A rise in NII, along with higher loan and deposit balances, aids BPOP's Q4 earnings. Yet, a rise in costs and a fall in fee income are headwinds.
Popular, Inc. (BPOP) Q4 2024 Earnings Conference Call Transcript
The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk's popular drug known for diabetes and weight loss.
Popular (BPOP) came out with quarterly earnings of $2.51 per share, beating the Zacks Consensus Estimate of $2.04 per share. This compares to earnings of $1.94 per share a year ago.
Alphabet subsidiary Google recently announced two major technical achievements with its Willow quantum computing chip. In response to the news, shares of Rigetti Computing (RGTI -3.16%) and D-Wave Quantum (QBTS -3.52%) during the next three weeks advanced 280% and 110%, respectively.
Popular (BPOP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.